.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Blocking Agent

October 1, 2003

New York - A recent in vitro study uncovered specific details of the immunoregulatory agent, fontolizumab (HuZAFTM), showing the biologic modifier as able to block transcripts induced by the naturally occurring human protein, interferon-gamma, said Jules Cohen, M.D., at the International Psoriasis Symposium.